Workflow
春立医疗: 2025年第一次H股类别股东大会决议公告
Zheng Quan Zhi Xing·2025-07-07 16:07

Group 1 - The company held its first H-share class shareholders' meeting for 2025 on July 7, 2025, in Beijing, where the board of directors proposed a general authorization for the repurchase of H shares [1][2] - The proposal requires approval from three shareholder meetings: the 2024 annual general meeting, the first A-share class meeting of 2025, and the first H-share class meeting of 2025, with more than two-thirds of the voting rights present at each meeting needed for approval [1][2] - The voting results showed that 100% of the H-share ordinary shareholders present voted in favor of the proposal, with no votes against or abstentions [2] Group 2 - The meeting was convened by the board of directors and chaired by the chairwoman, Ms. Shi Wenling, following legal and procedural requirements as per the Company Law and Securities Law [2][3] - The lawyers present confirmed that the meeting's procedures, participant qualifications, and voting results complied with relevant laws and regulations, deeming the resolutions passed as legal and valid [3]